Literature DB >> 27084519

Apelin/APJ system: a novel promising therapy target for thrombotic diseases.

Lanfang Li1, Jin Xu2, Linxi Chen3, Zhisheng Jiang4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27084519      PMCID: PMC4913519          DOI: 10.1093/abbs/gmw028

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


× No keyword cloud information.
  9 in total

Review 1.  Pathophysiology and prevention of sudden cardiac death.

Authors:  Vineet Goyal; Davinder S Jassal; Naranjan S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  2015-09-17       Impact factor: 2.273

Review 2.  Apelin/APJ signaling in hypoxia-related diseases.

Authors:  Lu He; Jin Xu; Linxi Chen; Lanfang Li
Journal:  Clin Chim Acta       Date:  2015-10-03       Impact factor: 3.786

Review 3.  Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases.

Authors:  Jiangang Cao; Hening Li; Linxi Chen
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

4.  Hypoxia promotes bone marrow-derived mesenchymal stem cell proliferation through apelin/APJ/autophagy pathway.

Authors:  Lanfang Li; Lifang Li; Zidong Zhang; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-03-02       Impact factor: 3.848

Review 5.  Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia.

Authors:  Vera Novakova; Gurpreet S Sandhu; Dan Dragomir-Daescu; Martin Klabusay
Journal:  Vascul Pharmacol       Date:  2015-08-05       Impact factor: 5.773

6.  Apelin-13 protects against apoptosis by activating AMP-activated protein kinase pathway in ischemia stroke.

Authors:  Yi Yang; Xiang-Jian Zhang; Li-Tao Li; Hai-Ying Cui; Cong Zhang; Chun-Hua Zhu; Jiang-Yong Miao
Journal:  Peptides       Date:  2015-11-26       Impact factor: 3.750

7.  Apelin: an antithrombotic factor that inhibits platelet function.

Authors:  Frédéric Adam; Abdel-Majid Khatib; Jose Javier Lopez; Camille Vatier; Sabrina Turpin; Adeline Muscat; Fabienne Soulet; Anne Aries; Isaac Jardin; Régis Bobe; Alain Stepanian; Dominique de Prost; Cédric Dray; Juan Antonio Rosado; Philippe Valet; Bruno Feve; Geraldine Siegfried
Journal:  Blood       Date:  2015-12-03       Impact factor: 22.113

8.  ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13.

Authors:  Li Yang; Tao Su; Deguan Lv; Feng Xie; Wei Liu; Jiangang Cao; Irshad Ali Sheikh; Xuping Qin; Lanfang Li; Linxi Chen
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-12-29       Impact factor: 3.848

Review 9.  Effects of Physical (In)activity on Platelet Function.

Authors:  Stefan Heber; Ivo Volf
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

  9 in total
  3 in total

Review 1.  Sodium sensitivity of blood pressure in Chinese populations.

Authors:  Yang Liu; Mengyao Shi; Jacquelyn Dolan; Jiang He
Journal:  J Hum Hypertens       Date:  2019-01-10       Impact factor: 3.012

2.  Apelin/APJ-Manipulated CaMKK/AMPK/GSK3β Signaling Works as an Endogenous Counterinjury Mechanism in Promoting the Vitality of Random-Pattern Skin Flaps.

Authors:  Zhi-Ling Lou; Chen-Xi Zhang; Jia-Feng Li; Rui-Heng Chen; Wei-Jia Wu; Xiao-Fen Hu; Hao-Chun Shi; Wei-Yang Gao; Qi-Feng Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-01-25       Impact factor: 6.543

3.  Uremic Apelin and Leucocytic Angiotensin-Converting Enzyme 2 in CKD Patients.

Authors:  Bogusz Trojanowicz; Christof Ulrich; Matthias Girndt
Journal:  Toxins (Basel)       Date:  2020-11-26       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.